We previously performed a comparative assessment of tissue-level vascular physiological parameters in mice and rats, two of the most commonly utilized species in translational drug development. The present work extends this effort to non-human primates by measuring tissue-and organ-level vascular volumes (V v ), interstitial volumes (V i ), and blood flow rates (Q) in cynomolgus monkeys. These measurements were accomplished by red blood cell labeling, extracellular marker infusion, and rubidium chloride bolus distribution, respectively, the same methods used in previous rodent measurements. In addition, whole-body blood volumes (BV) were determined across species. The results demonstrate that V v , V i , and Q, measured using our methods scale approximately by body weight across mouse, rat, and monkey in the tissues considered here, where allometric analysis allowed extrapolation to human parameters. Significant differences were observed between the values determined in this study and those reported in the literature, including V v in muscle, brain, and skin and Q in muscle, adipose, heart, thymus, and spleen. The impact of these differences for selected tissues was evaluated via sensitivity analysis using a physiologically based pharmacokinetic model. The blood-brain barrier in monkeys was shown to be more impervious to an infused radioactive tracer, indium-111-pentetate, than in mice or rats. The body weight-normalized total BV measured in monkey agreed well with previously measured value in rats but was lower than that in mice. These findings have important implications for the common practice of scaling physiological parameters from rodents to primates in translational pharmacology.
INTRODUCTION
The scaling of various physiological parameters across species has been performed for several decades, largely for the purpose of translational pharmacology [1] [2] [3] [4] [5] [6] . Knowledge of physiological parameters is required for derivation of drug concentrations within compartments such as interstitial fluid (often the drug site of action, particularly for biologics) [7] [8] [9] and is an important component of many physiologically based pharmacokinetic (PBPK) models [10] [11] [12] [13] [14] [15] [16] [17] [18] . Human tissue/ organ-level physiological parameters are often derived by allometric scaling of corresponding animal data ( [5, 19, 20] ). For biologic drugs with minimal cell partitioning (e.g., antibodies), blood correction of whole tissue concentrations and subsequent conversion into interstitial fluid concentrations requires knowledge of the fractional composition of vascular and interstitial spaces, respectively, within each tissue [7, 8] . We previously reported measurement of tissuelevel vascular volumes (V v ), interstitial volumes (V i ), and rates of blood flow (Q) in several immunocompromised mouse strains [21] [22] [23] [24] [25] . More recently, we expanded our investigations to include immunocompetent mice [26, 27] and rats [28] , but comparable experimental data in primates remains unavailable for some parameters (e.g., V i ) and is Danielle Mandikian and Isabel Figueroa contributed equally to this work.
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reported only in limited tissues for others. The cynomolgus monkey is often the nonclinical species of choice, particularly in antibody development, for a number of reasons: the higher degree of target homology with human makes interspecies cross-reactivity more likely, the increased pharmacological and toxicological relevance in cases where target biology is similar to human, and the availability of robust, highly validated methods for predicting clinical pharmacokinetics based on monkey studies. Additionally, generating more accurate and methodologically consistent physiological parameter values will improve preclinical to clinical allometric scaling, prospective clinical PK/PD simulations, and other related calculations (e.g., predicting target-mediated drug disposition based on observed/assumed volumes of distribution), potentially resulting in decreased animal usage. Herein, we address this gap by measuring the same three parameters in cynomolgus monkeys using identical experimental approaches as were used in rodents [8, 28] . In addition, total blood volumes (BV) were calculated for monkey and rodents (using current and historical data, respectively) to gain a further quantitative understanding of vascular physiological parameters across these species commonly used in drug development.
Accurate measurement of V v (i.e., residual blood volume) in tissues requires the use of very large molecules that are unable to extravasate (Fig. 1) . Radiolabeled albumin or immunoglobulin uptake should not be used to estimate V v as these molecules are known to exhibit transudation (i.e., extravasation) into interstitial spaces of tissues even at early time points [29] . Consequently, we selected a red blood cell (RBC) radiolabeling method that relies on stannous ion (Sn +2 )-mediated reduction of technetium [30] . After priming RBCs with Sn +2 (often termed pre-tinning), technetium in the form of pertechnetate ion ( 99m TcO 4− ) is introduced and becomes reduced by Sn +2 leading to stable binding to the beta chain of hemoglobin with high labeling efficiency. A similar protocol is used for clinical blood pool imaging [31] and has been back-translated for measuring V v in mouse xenograft models [32] . However, the portion of Tc-labeled RBCs present. To address this issue, we modified the clinical in vivo procedure for quantitative V v measurement in rodent tissues using a transfusion approach in which pre-tinning, 99m TcO 4− labeling (at high specific activity), and purification (via extravasation and/or renal filtration) occur in a donor animal [21, 22, 26, 28] . The 99m Tc-labeled blood from this donor can be subsequently collected at euthanasia and carefully reinjected into naïve animals for V v determination. In addition to providing V v measurements at the tissue level, data from RBC labeling can also be used to calculate hematocrit [33] and total BV [34, 35] .
Historically, measurement of V i has relied on the use of several small molecules as extracellular tracers, including sucrose, inulin, chloride, sulfate, and the radiometalpolyaminopolycarboxylate complex chromium-51-ethylenediaminetetraacetic acid ( 51 Cr-EDTA) [36, 37] . More recently, preclinical measurement of interstitial volume in tumors has been accomplished by indium-111-labeled diethylenetriamine pentaacetate (i.e., 111 In-pentetate or 111 In-DTPA) [38, 39] . Such measurements rely on two assumptions: (1) tracer is excluded from all living cells (an  appropriate assumption for a polar, charged molecule like   111 In-DTPA) and (2) tracer is in steady-state equilibrium between plasma and interstitial fluid at time of measurement (Fig. 1) . In preclinical studies, others have either suppressed renal filtration (nephrectomy, renal ligature) or applied a constant infusion of tracer in order to maintain constant plasma levels and accurately derive V i values in selected tissues [37] . We previously employed constant intravenous infusion of 111 In-DTPA followed by prompt euthanasia and tissue harvest [21, 26, 28] . This approach allows us to measure V i in most tissues except brain and eye (because 111 In-DTPA is excluded) and kidneys (because 111 In-DTPA is excreted). Measurement of Q (blood flow rate) utilizes certain tracers such as the noble gas xenon (Xe) [40] and alkali metal ions (K + /Rb + ) [41] that are completely extracted by tissues from circulating blood on first pass, such that extravascular tracer levels in each tissue shortly after tracer administration can be used to approximate blood flow rate to that tissue as a fraction of cardiac output (Fig. 1 ). This rapid extraction phenomenon has been exploited to measure Q in tumors and other tissues preclinically [32, [42] [43] [44] , with further efforts for clinical translation via 81 Rb positron emission tomographic imaging in patients [45] . The absence of significant Rb + washout following extraction is due, in part, to its active transport into cells via Na-K pumps (i.e., Na + /K + -ATPases) [46] , particularly in cardiac myocytes [47] . Consistent with this concept, the amount of measured 42 K + and 86 Rb + has been shown to be relatively constant from as early as 9 s to as late as 120 s post administration [41] . The two most common indicators for measuring regional blood flow rates (i.e., relative distribution of cardiac output to various tissues) are radiolabeled microspheres and the radioactive potassium ion analogue 86 Rb + . A direct comparison of these two methods yielded largely similar results in rat [48] . Most preclinical reports on methods for measuring Q have been limited to xenograft tumors and a few selected tissues, although compilations of data across species are available [49] . However, the use of various techniques and/or strains has thereby motivated extension of this approach to measure Q in a much wider range of tissues in mice [26] and rats [28] ; however, brain and eye should be excluded due to exclusion of 86 Rb by the blood-brain and blood-ocular barriers [50] .
Using the aforementioned techniques, we measured V v , V i , and Q in vivo across a wide range of tissues in mice, rats, and monkeys for the purpose of informing translational pharmacology as well as physiologically based pharmacokinetic (PBPK) modeling efforts. A recently published PBPK model [13] compiled a list of previously measured (or scaled/ assumed) V v , V i , and Q values from a diverse set of published literature [17, 18, [51] [52] [53] for the species considered here; however, as is typical in PBPK modeling efforts, these values were obtained using a wide variety of experimental techniques or were scaled from other species in cases where measured values were unavailable. In some cases, nominal values (e.g., 10% vascular volume for well-perfused tissues) were assumed based on little to no experimental data for the specific organ of interest [17] . In this study, we aim to address (1) the limited availability of tissue-level parameters in primates [18] , where scaled or nominal values are often used when measured values are unavailable and (2) reduce the variability in these physiologic values by measuring V v , V i , and Q in cynomolgus monkeys using standardized methods that we have also previously applied to rats [28] and mice [26] .
MATERIALS AND METHODS
Ethical Approval. All procedures were conducted in accordance with the Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals, the Office of Laboratory Animal Welfare, and the IACUC at the in-life study site. Care and housing were USDA regulatory compliant.
Animal Care. A total of eight drug-naïve cynomolgus monkeys (Chinese origin) ranging from 2 to 7 years of age and from 2 to 5 kg weight from Covance Research Products, Inc., (Alice, TX) or from a Covance stock colony were used. Tissues were harvested from six monkeys following euthanasia (three each for V v /Q and V i ), while two additional monkeys served as blood donors without requiring euthanasia. Animals were allowed to commingle during the 1-week acclimation period (prior to administration of radionuclides), but were housed individually in stainless steel cages during the < 1-day test period. Certified Global Primate Diet No. 2055 (Harlan Teklad, Inc.) and fresh water (ad libitum) were provided and supplemented with appropriate fruits and cereals as treats. Cage enrichment devices were used for environmental and psychological enrichment. Environmental controls were set to maintain a temperature of 20 to 26°C, a relative humidity of 50% ± 20%, and a 12-h light/12-h dark cycle.
Derivation of Total Blood Volumes. The total blood volume of each monkey was calculated from the total radioactive dose in counts per minute (CPM) of 99m Tcfortified blood and the radioactive ( 99m Tc) concentration in blood at time of euthanasia in CPM per microliter as follows:
The same approach was used to calculate total blood volumes of rats and mice from our previously reported studies [21, [23] [24] [25] [26] [27] [28] , and blood volumes were normalized to body weight (kg) for comparison across species.
Measurement of Organ-Level Vascular Volumes and
Rates of Blood Flow. The vascular spaces of monkey tissues were measured using a previously reported indirect red blood cell (RBC) labeling/transfusion method [22] based on protocols used in both clinical blood pool imaging [31] and preclinical studies [32, 54, 55] . Using a dual radionuclide detection strategy, regional blood flow rates (Q) in various organs and tissues were determined in the same animals by prompt euthanasia after intravenous bolus injection of 86 Rb chloride ( 86 RbCl) [32, [42] [43] [44] [45] . The RBC labeling method relies on tin-mediated reduction of 99m Tc pertechnetate 
Rb
+ quickly extravasates and is sequestered into cells via sodium/potassium ion transporters intracellularly so that it may bind to the beta chain of hemoglobin [30] . An appropriate number of animals were pre-screened to ensure donor blood compatibility, evident by a lack of antigen-antibody reaction resulting in clumping or hemagglutination in blood samples. TechneScan PYP™ (i.e., stannous pyrophosphate kits for preparation of 99m Tc pyrophosphate injection) were obtained from a radiopharmacy and used according to label instructions for the in vivo method of blood pool imaging with the appropriate human-to-monkey scaling based on relative body weight. Each reconstituted clinical kit vial of TechneScan PYP™ contains 4 mg of tin chloride (three human doses) in 3 mL. Two donor cynomolgus monkeys received bolus IV injections of stannous pyrophosphate. Approximately 30 min later, blood (approximately 3 mL) was collected into tubes containing K 2 EDTA anticoagulant and maintained at ambient temperature. Approximately 7 mCi of 9 9 m Tc pertechnetate saline solution (approximately 165 μL) was added to each 3 mL sample of blood. The fortified samples were gently inverted to mix and incubated with gentle rotation at ambient temperature for approximately 20 min. Three study animals (3.3-4.3 kg) received a bolus IV injection of approximately 0.5 mL of 99m Tc-fortified blood (~1 mCi) followed by 0.1 mL of 86 Rb chloride (PerkinElmer,~100 μCi) approximately 30 min later. Approximately 1 min after the 86 RbCl dose, blood was collected into tubes containing K 2 EDTA anticoagulant and placed on wet ice prior to subsampling and centrifugation to obtain plasma. Animals were euthanized within 2.5 to 3.5 min after the 86 RbCl dose via an overdose of sodium pentobarbital. Following blood collection, tissues were collected as described below for prompt radioanalysis of 99m Tc (140 keV gamma energy, t 1/2 6 h), followed by radioanalysis of 86 Rb (1774 keV gamma energy, t 1/2~1 8.6 days) subsequent to 99m Tc decay. V v was calculated from 99m Tc counts as follows:
By converting to milliliters per gram (i.e., V v / 1000), one can easily derive the fractional vascular volume (γ), a unitless value if one assumes that blood and tissue have equal densities. Importantly, drug concentrations in tissues (C t ) may be corrected for circulating drug in blood based on V v using the following equation, where C b (μg/μL) is the concentration of drug in whole blood:
Rates of blood flow (Q) were calculated from 86 Rb counts where total cardiac outputs (CO total ) are 8000, 74,000, and 884,000 μL/min for mice, rats, and monkeys, respectively [52] , as follows:
The cardiac output for the monkeys weighing 3.8 kg (884,000 μL/min) was derived by allometrically scaling (using an exponent of 0.75) [20] the value previously reported for monkeys weighing 5 kg [52, 56] . Values for 20 and 250 g mice and rats, respectively, were used without scaling.
Measurement of Organ-Level Interstitial Volumes. The interstitial spaces of monkey tissues were measured by continuous infusion of the extracellular marker, 111 In-DTPA [38, 39] . In-DTPA (clinical grade, GE Healthcare) was administered (~3 mCi, 11-12 mL) as an intravenous infusion over approximately 1 h. Three animals (2.7-5.2 kg), previously acclimated to the procedure, were restrained in chairs throughout dose administration. Upon completion of the infusion, blood (at least 5 mL, collected into a 6-mL vacutainer) was immediately (within 1 min after the end of infusion) collected into tubes containing K 2 EDTA anticoagulant. Blood samples were placed on wet ice prior to subsampling and centrifugation to obtain plasma. Animals were euthanized within 1.5 min after the end of infusion via overdose of sodium pentobarbital anesthesia. Tissues were harvested as described below followed by radioanalysis for 
The above equation assumes that 111 In-DTPA is in steady-state equilibrium between plasma and tissue interstitial fluid at time of euthanasia and tissue harvest. Importantly, for drugs with little to no cell partitioning (e.g., antibodies), conversion of blood-corrected whole tissue drug concentrations (C t,blood corrected ) to interstitial concentrations (C i ) may be achieved using the following equation:
Blood-Brain Barrier Permeability. Blood-corrected brain levels of 111 In-DTPA, normalized to plasma levels, were compared across species as indicators of blood-brain barrier permeability. The calculation is analogous to the equation for V i as described above but is designated as a brain partitioning coefficient (K p ) to highlight the lack of physiological relevance to brain V i .
Tissue Handling and Analysis. Harvested tissues included brain, colon (without contents), eyes, fat (subcutaneous), heart, ileum (without contents), kidneys, liver, lungs, muscle (from the thigh), skin (dorsal), and spleen. Brain, heart, kidneys, and lungs were collected in entirety, weighed, divided into pieces, supplemented with reverse osmosis water (approximately twice the sample weight), homogenized in a blender, and divided into duplicate aliquots for analysis by solid scintillation (i.e., gamma) counting. Colon and ileum were collected in entirety, emptied of their contents, weighed, and divided into duplicate representative samples (~1 g each). Duplicate representative samples of fat, muscle, and skin were collected. Colon, eyes, fat, ileum, muscle, and skin samples were not homogenized; instead, samples were lightly rinsed and blotted dry, weighed, and placed on wet ice prior to transfer for analysis by solid scintillation counting. Blood was mixed and duplicate weighed aliquots were analyzed by solid scintillation counting. Samples were analyzed for at least 1 min or 1,000,000 counts. As applicable, one complete set of samples (one aliquot per sample) was counted; the second set was then analyzed.
Allometric Analysis. To evaluate the scalability of measured parameters across different species, we conducted an allometric analysis. Tissue weight-normalized values were multiplied by their respective organ weights (Table S1 ) in order to express measured values on a per-organ basis (Q in μL/min, V v in μL, V i in μL). Estimated tissue-specific values were related to total animal body weights (BW) by the equation:
where Y corresponds to V v , V i , and Q and BW is the total body weight for each animal. A and b, the allometric coefficient and exponent, are fitted parameters (Table S2) . A value of b = 1 suggests that the parameter Y scales proportionally with BW and b values lower or greater than 1 suggests that Y scales less or more than BW proportionally, respectively. Extrapolation of the linear regression lines to 70 kg was used to estimate values in human, which were subsequently normalized using human organ weights from the literature [52] .
Sensitivity Analysis. We used a previously published PBPK model [10] , which we scaled from mouse to cynomolgus monkey (Table S3) , to evaluate the impact of uncertainty in V v , V i , and Q on simulated total uptake of a 150-kDa monoclonal antibody in selected fast and slow perfused tissues. Using the scaled cyno model, concentration-time curves were simulated using V v , V i , and Q values measured here and those compiled by Shah and Betts [13] . The area under each simulated % injected dose versus time curve from 0 to 7 days (AUC 7 ) was calculated and compared.
RESULTS
Total Blood Volumes. Measured whole-body blood volumes are shown in Table I . Total BV values (mL) were 181 ± 24 in monkey and 10.2 ± 0.5 in rat and ranged from 1.3 ± 0.1 to 2.1 ± 0.1 in mice. Weight-normalized BV values (mL/kg) were 47.7 ± 0.8 in cynomolgus monkeys and 48 ± 2 in Sprague-Dawley rats and ranged from 59 ± 5 for C57BL-6 to 109 ± 4 for C.B-17 SCID beige mice. Higher weightnormalized BVs were measured in immunocompromised strains (108 in nude and 109 in SCID) relative to immunocompetent strains (ranging from 59 to 78) despite a similar body weight range.
Vascular Volumes. V v in monkey tissues, derived from 99m Tc labeling of red blood cells and expressed in microliters of blood per gram (μL/g) of tissue, are presented in the first column of Table II . V v in muscle was roughly consistent across cynomolgus monkeys and our previously measured values in other species (Table II, 
One notable exception was lung, for which the V v value in rats (538 ± 69) was significantly higher than that in monkeys (126 ± 29) and mice (ranging from 125 ± 17 to 214 ± 78). While the high rat lung V v was reproduced in a second study, we suspect that blood pooling during euthanasia and harvest exaggerated the value as the mean rat lung weights were higher than expected.
Interstitial Volumes. Measured tissue-level V i in cynomolgus monkeys, derived from 111 In-DTPA levels and expressed in microliters of interstitial fluid per gram (μL/g) of tissue, are presented in the first column of Table III . It is critical to note that 111 In-DTPA does not provide physiologically meaningful measurements of V i in kidney and brain/eye due to probe clearance and lack of blood-brain/ ocular-barrier permeability, respectively. A remarkably good agreement in V i on a per-gram-tissue basis was observed across most monkey tissues analyzed here and previously analyzed rodent tissues. For instance, measured V i in muscle were fairly consistent across cynomolgus monkeys and our previously measured values in other species (Table III, Rates of Blood Flow. Measured tissue-level rates of blood flow (Q) in cynomolgus monkeys derived from 86 RbCl expressed in microliters of blood per gram of tissue per minute (μL/g/min) are presented in the first column of Table IV . Importantly, 86 RbCl cannot freely cross the bloodbrain and blood-ocular barriers so values for brain and eyes are not shown [50] . It should also be noted that 86 RbCl may somewhat exaggerate Q in heart due to cardiac sequestration of Rb + through K + channels and Na + /K + -ATPase pumps [57] . Q in muscle for monkeys (231 ± 54) was in good agreement with previously measured rodent values (Table IV, columns  2-7) , including 190 ± 38 in rats and ranging from 186 ± 47 to 300 ± 34 in mice. Monkey tissue Q values ranged from 93 ± 23 in skin to 3365 ± 961 in kidneys. The Q value in monkey spleen (471 ± 99) was comparable to previously measured values in rats (572 ± 134) but generally higher than previously measured values in mice (ranging from 124 ± 51 to 326 ± 43).
Blood-Brain Barrier Permeability. Brain K p values measured in monkeys (0.003 ± 0.001) were significantly lower than previously measured values in rats (0.019 ± 0.007) and mice (ranging from 0.016 ± 0.007 to 0.035 ± 0.012) (Fig. 2) .
Allometric Analysis. Results from the allometric analysis are shown in Fig. 3 . Qualitatively, the observed data is consistent with the allometric relationship, where values of V v (μL), V i (μL), and Q (μL/min) across species are largely dependent on BW. Parameter values for human are obtained by extrapolation of the regression lines to 70 kg body weight (Table V) . Human parameters were all generally lower than the corresponding monkey parameters on a tissue weightnormalized basis. For instance, V v (μL/g), V i (μL/g), and Q (μL/g/min) were 59, 87, and 173 in human lung compared to our measured values of 126, 247, and 570 in monkey lung. Most exponents were between~0.9 and 1. An exception was V i in liver which was 0.8, Q in kidney and spleen which werẽ 0.85, and V v in kidney which was 0.87 (Table S2 ). The allometric plots with 95% confidence intervals are provided in Fig. S1 . Sensitivity Analysis. The sensitivity analysis compares the impact of various values (our measured values versus previously assembled literature values [13] ) of V v , V i , and Q on AUC 7 of an antibody in muscle and liver, in cynomolgus monkeys (Table S3 ). AUC 7 values of simulated %ID versus time curves in both tissues are most sensitive to changes in V v , where for muscle a 131% increase in AUC 7 results from using the literature value of V v (40 μL/g) versus the value estimated here (7 μL/g) and for liver a 55% increase in AUC 7 results from using the literature value of V v (155 μL/g) versus the value estimated here (92 μL/g). The impact of V i on AUC 7 is less pronounced, with almost no increase in AUC 7 for muscle when using the literature value (130 μL/g) versus the value estimated here (108 μL/g) and a modest increase in liver (which has much higher vascular permeability) of 18% when using the literature value (200 μL/g) versus the value estimated here (100 μL/g). For large molecular weight compounds such as the 150-kDa antibody considered here, extravasation from the vascular to interstitial space is the rate-limiting step for tissue uptake; therefore, AUC 7 is almost completely insensitive to the range of Q values evaluated for muscle and liver (37-416 μL/min/g), consistent with previous findings [16, 17] . Although not evaluated here, one would expect small molecule tissue uptake to be sensitive to Q [58] . The sensitivity analyses discussed here and in previous works [16, 17] are, strictly speaking, valid only for each respective model/parameter combination. As good practice, parameter sensitivity analysis should be re-evaluated each time the model is fitted to a new biodistribution data set.
DISCUSSION
Prior to this study, a relatively limited amount of organlevel physiological data in primates was available; furthermore, primate and rodent data were often acquired by different methods [18] . Organ-level values used by PBPK modelers, exemplified by a recent example [13] , are usually obtained from various literature sources that include compilations of previously measured and assumed nominal values. In many cases, citations for physiological parameter values used in modeling papers refer to earlier modeling or review papers, such that ascertaining the original source and, importantly, the associated in vivo measurement methods (if M, male; F, female; n/a, not available a Measured in two separate studies any) is challenging. Our experimental strategy aimed to measure three critical parameters-V v , V i , and Q-in cynomolgus monkeys using protocols as consistent as possible with those we previously used in rodents [28] . This approach facilitates direct comparison of parameters, estimated using the same methodology, across three species-mice, rats, and monkeys-commonly used in translational pharmacology and drug development. Since our measurements were performed in cynomolgus monkeys of Chinese origin, it should be noted that parameters may vary across other monkey populations including other cynomolgus populations (e.g., Mauritian). Furthermore, the possibility that transport and other experimental stresses may have influenced our results cannot be dismissed; however, we included an acclimation period, commingling when feasible, treats, and other elements in our study design in order to minimize experimental stress as much as possible [59, 60] . With some important exceptions, our results measured in monkeys were consistent with our previous results obtained in mice and rats, where many of the measured tissue-specific body weight-normalized parameter values were largely similar across species (Tables II, III, IV) . In general, similar values were measured for poorly perfused tissues like muscle while greater interspecies variability was observed for more highly perfused organs (e.g., heart, lung, liver). Furthermore, most of the V v , V i , and Q values observed in this study are in reasonably good agreement with values that have been assembled by Shah and Betts for PBPK modeling [13] ; however, there are certain exceptions worth noting. For instance, sizeable differences were observed between values [25] (N = 4) SM intestine 16 ± 2 26 ± 8 [22 ± 3] 16.4 ± 0.4 6 ± 1 [6.8 ± 0.4] 13 ± 9 8 ± 2 7 ± 3 10 ± 5
LG intestine 27 ± 7 20 ± 4 [19 ± 5] 11 ± 5 5.3 ± 0.6 n/a n/a n/a 13 ± 3 11 ± 1.6 9 ± 2 n/a n/a n/a n/a Thymus n/a 18 ± 4 [17 ± 4] 140 ± 60 14 ± 8 n/a n/a n/a n/a Pancreas n/a 30 ± 4 [30 ± 6] 15 ± 14 8 ± 2 n/a n/a n/a n/a Lymph node n/a 25 ± 9 [6 ± 8] 17 ± 5.5 5.2 ± 0.9 n/a n/a n/a n/a Ovaries n/a 60 ± 24 [125 ± 86] n/a n/a n/a n/a n/a n/a Eyes 4 ± 1 n/a n/a n/a n/a n/a n/a n/a SM, small; LG, large; n/a, not available reported by Shah and Betts [13] and those measured in this study for V v in muscle, brain, and skin (our values lower in all three species); Q in muscle and adipose (our values higher in monkey); and Q in heart, thymus, and spleen (our values lower in mice and rats). Our tissue-level V v (μL/g) values measured here in monkey and previously in mice and rats [28] were mostly consistent across these species (Table II) . We are aware of only one publication that reports tissue-level V v measurements in non-human primates; our cynomolgus monkey values differ greatly from the reported rhesus monkey values (our values are all lower, some by an order of magnitude) whose method of measurement could not be ascertained [12] . Lung V v in monkeys agreed well with our values in mice but was significantly lower than those in rats (Table II) . Our murine muscle V v ranged from 5 to 7 μL/g, consistent with previous reports of~5 to 8 μL/g measured by 51 Cr-labeled RBCs in murine leg muscle [38, 39] . Generally good agreement was also noted between the measured rat V v values that we observed and those reported by Khor et al., (measured by 51 Cr-labeled RBCs) in intestine, stomach, brain, muscle, kidney, liver, lung, and spleen (but with poor agreement in lung) [61] . Our measured brain V v values in rats (9 ± 1) and mice (8-11 μL/g) agree well with previously published values measured by 14 C-labeled sucrose in rats (13 ± 3) [62] and by 3 H-labeled inulin in mice (9.4) [63] . Our measured rat V v values (μL/g) in skin (13 ± 3), muscle (7 ± 1), lung (538 ± 69), and kidney (184 ± 18) agreed reasonably well, with the exception of lung, with values previously measured by 51 Cr-labeled RBCs (6.7, 6.5, 218, and 183, respectively) [64] . However, in comparison to the values assembled by Shah and Betts [13] , our measured V v 's are consistently lower in muscle and skin and higher in lung (except mouse) and kidney (Table S4 ) across all species considered here. These disagreements may reflect the fact that V v values in Shah and Betts [13] were gathered from various sources which include values scaled from other species (e.g., dog) [18] and/or measured by different techniques (e.g., radiolabeled albumin) [65] . Another possible source of variability in various measured V v values may be due to circadian effects, which have been reported in nude mice where ranges of~70-200, 50-100, and 60-180 μL/g in liver, kidney, and lung, respectively, have been observed [32] .
We are not aware of any previous reports of tissue-level V i measurement in non-human primates. Our measured V i values in most tissues were remarkably consistent across species (Table III) and agreed well with values reported in Shah and Betts [13] (Table S5) . Our muscle V i ranged from 48 to 108 μL/g which is roughly consistent with previous reports of~150 μL/g (measured by 111 In-DTPA) in murine leg muscle [38, 39] .
Importantly, blood-brain barrier permeability to 111 In-DTPA (represented as brain K p ) in monkeys was much lower than that in rodents (Fig. 2) . The observed 5-10-fold discrepancy is consistent with previous reports of brain antibody concentrations reaching only 0.01-0.02% of steadystate serum concentrations in cynomolgus monkeys [66, 67] , in contrast with reports of 0.1% in mice [68] . Although it is possible that these interspecies differences in apparent antibody BBB permeability could be due to differences in binding affinity of the antibody Fc region for the neonatal Fc receptor, our results here suggest that more fundamental differences in BBB permeability may exist between species since we used a non-FcRn-binding small molecule probe ( 111 In-DTPA) to measure K p . This finding is of great significance in the development of drugs for neurological diseases, as it has significant implications with respect to our ability to translate brain PK/PD data across species. Simply n/a n/a n/a Thymus n/a 197 ± 53 162 ± 114 204 ± 89 n/a n/a n/a Pancreas n/a 120 ± 63 93 ± 38 70 ± 31 n/a n/a n/a Lymph node n/a 178 ± 49 390 ± 178 153 ± 117 n/a n/a n/a Ovaries n/a 111 ± 24 n/a n/a n/a n/a n/a SM, small; LG, large; n/a, not available scaling from mouse or rat to monkey and human in physiologically based models may exaggerate the ability of antibodies and other drugs with low brain partitioning to reach the site of action.
Our measured Q values in small intestine, large intestine, liver, kidneys, heart, and spleen agreed reasonably well with previously measured values in cynomolgus monkey (using radiolabeled microspheres) reported by Gelman et al. LG intestine 458 ± 209 830 ± 361 520 ± 40 263 ± 34 n/a n/a n/a Stomach n/a 561 ± 79 241 ± 39 228 ± 27 n/a n/a n/a Thymus n/a 381 ± 68 237 ± 99 141 ± 17 n/a n/a n/a Pancreas n/a 756 ± 138 337 ± 177 258 ± 45 n/a n/a n/a Lymph node n/a 219 ± 98 381 ± 229 137 ± 9 n/a n/a n/a Ovaries n/a 797 ± 43 n/a n/a n/a n/a n/a SM, small; LG, large; n/a, not available In-DTPA as a measure of blood-brain integrity in cynomolgus monkeys determined in this study, compared to tissues from other laboratory animal species (Sprague-Dawley rat and various mouse strains) measured previously (Table IV , column 1) [69] . Compared to rhesus monkey results reported by Forsyth et al. (also using microspheres) [56] , our Q values for skin, heart, small intestine, large intestine, spleen, and kidney also agreed reasonably well (Table IV, column 1) ; however, our Q values in lung and liver of 570 and 416 µL/g/min were higher than the reported rhesus values of 180 and 340 [56] . Interestingly, Q values in liver and spleen trended higher in monkey than in mice (as did rat Q values), but were comparable to rodent values in muscle and skin (Table IV) . Our muscle Q values of 200 and 190 µL/g/ min in mice and rats agreed well with previously reported values of 236 and 237, respectively [20] . Similarly, our skin Q values of 99 and 142 µL/g/min agreed reasonably well with previously reported values of 185 and 141 in mice and rats, respectively [20] . Compared to values assembled by Shah and Betts [13] , the following were observed: (1) our heart Q values were lower in rodents, but higher in monkey (Table S6) , (2) our lung Q values could not be directly compared since lung Q is defined as total cardiac output, and (3) our muscle and adipose Q values were each roughly 6-fold higher than the respective values in monkey. Unfortunately, we were unable to ascertain the method(s) by which Q values in Shah and Betts [13] were measured or derived.
Our measured monkey BV of 47.7 ± 0.7 (Table I) is lower than the range of 55-75 mL/kg reported for cynomolgus monkey [70] . It is, however, within the measured range for rhesus monkeys (44-67 mL/kg) [70] despite being considerably lower than a value of~149 mL/kg previously used for PBPK modeling [12] . Although weight-normalized BVs were identical between monkeys and rats, they were consistently higher for mice (Table I) . Furthermore, immunocompromised strains (nude and SCID) had higher BVs than immunocompetent strains, a trend that has not previously been noted to our knowledge. Our measured rat BV of 48 ± 2 mL/kg is lower than previous reports of~64 mL/kg (measured, range 58-70) [34, 70] and~74 mL/kg (previously used for PBPK modeling) [12] . Importantly, BV values are highly dependent on measurement method as values of~94 and~65 mL/kg were reported for rats using 131 I-labeled albumin and 51 Crlabeled RBCs, respectively [35] . Our measured values in mice (60 ± 9 to 109 ± 4 mL/kg) are roughly consistent with a previously reported range of 85-95 mL/kg in CSI and CBA mice [71] . Others have noted differences in mouse BV depending on methodology, with values of 50-59 and 73-103 mL/kg using 59 Fe-labeled RBCs and 59 Fe-labeled transferrin, respectively [72] . These two 59 Fe-labeling-based techniques also led to distinct ranges for venous (0.47 to 0.52) and whole-body (0.30 to 0.34) hematocrits in mice [72] , with similar trends in rats [35] and humans [73] [74] [75] [76] . Differences between venous and whole-body hematocrits have been attributed in part to the spleen acting as a reservoir for RBCs [77] , and a similar mechanism may influence BV measurements. Blood has been reported to constitute 4.9, 7.4, and 7.9% of body weight in mice, rats, and humans, respectively, equivalent to 49, 74, and 79 mL/kg (assuming density of 1 g/ mL) [18] . However, our data seem to indicate an opposite trend, with lower body weight-normalized volumes of blood in higher species, roughly consistent with values of approximately 78 and 55 mL/kg reported for mouse and rat, respectively [20] . Furthermore, our results are roughly consistent with a previously reported allometric scaling method in which blood weight is equal to 0.055 multiplied by body weight to the power of 0.99 [1] .
Overall, our allometric analysis revealed the expected body weight dependence of V v , V i , and Q (Fig. 3) . Scaling exponents for V i and V v suggest that lung and liver vary near body weight proportionally, while spleen has a more shallow slope with respect to BW (Table S2 ). The extrapolated human Q values of 366, 2188, 1273, and 169 μL/g/min in liver, kidney, heart, and spleen (Table V) were lower (except heart) than human values of 806, 4000, 727, and 428 reported in Davies and Morris [52] . Note that Q values were calculated from CO values (8, 74 , and 1086 mL/min for a 0.02-kg mouse, 0.25-kg rat, and 5-kg monkey, respectively) obtained from a separate report [52] in which CO (at least one of which is a measured value [56] ) scales with an exponent of~0.9.
One technical challenge we faced was that the size of monkey tissues limits the ability to analyze whole tissues by solid scintillation (i.e., gamma) counting as was previously done for most mouse and rat organs. One possible approach was to collect representative sections; however, we were concerned that the complex structures of organs like brain, heart, kidneys, and lungs might introduce bias into our measurements if the section analyzed did not accurately represent the organ as a whole. As such, these entire organs were homogenized so that aliquots could be counted. In contrast, the n/a, not available representative sectioning approach (in duplicate, to minimize bias) was applied to intestines (ileum and colon), muscle, fat, and skin. It should be noted that representative sections of these tissues were also used to derive our previous parameter values in rodents. A second scaling challenge was the large blood volume of monkeys (approximately 180 mL), which diluted the 99m Tc activity in our in vivo RBC labeling/transfusion protocol to such an extent that this method would have required working with excessive amounts of radioactivity to maintain sufficient gamma counting sensitivity. To address this challenge, we adapted an alternative in vivo/in vitro clinical protocol [78] in which pre-tinning is accomplished in vivo while 99m TcO 4− labeling is accomplished in vitro but without requiring centrifugation to preserve the integrity of RBCs. To ensure that our data in monkeys can be compared to our previous data in rodents, we ensured that non-RBC-associated levels of 99m Tc were low by centrifuging aliquots and counting plasma and pellets separately. Furthermore, any damage to RBCs would likely result in elevated uptake in spleen (the sequestration site for damaged or aging RBCs); however, spleen V v values were similar between monkey and rodents ( Table II) , suggesting that RBC damage did not occur.
CONCLUSION
In summary, our work addresses the limited availability of tissue-level physiological parameters in primates in the literature, and our allometric analysis approach allowed extrapolation of human V v , V i , and Q values based on preclinical knowledge. While the majority of our measured values agree well with previously published values [13] , some differed by as much as 6-fold which, particularly in the case of large tissues, may be impactful as illustrated by sensitivity analysis which shows that PBPK model simulations are very sensitive to changes in V v . The finding that the blood-brain barrier was more impervious to intravenously infused 111 In-DTPA in monkey than in rodents was surprising and warrants further investigation, as does the observed trend towards higher weight-normalized blood volumes in immunocompromised mice relative to immunocompetent strains. Overall, the data herein support previous assumptions that V v , V i , and Q in tissues are roughly body weight proportional across species, but that tissuespecific deviations warrant the use of measured, species-specific values.
